Symphony’s Strategic Advisory Committee is comprised of leaders from some of the most successful biopharmaceutical companies and medical research institutions in the world. The Committee’s role is to provide overall strategic input and selectively assist with the investment process.
Symphony also accesses a deep network of leading physicians, scientists and other experts who selectively participate in aspects of the investment process. Most are affiliated with major academic institutions or have particular expertise and experience pertinent to biopharmaceutical product development or the FDA regulatory process. Many of these individuals have worked with Symphony on its private equity fund investments.